Crestone - Crunchbase Company Profile & Funding

Q: Where is Crestone's headquarters?

Crestone is located in Boulder, Colorado, United States.

Q: Who invested in Crestone?

Crestone has 2 investors including National Institute of Allergy and Infectious Diseases And Cystic Fibrosis Foundation.

Q: When was the last funding round for Crestone?

Crestone closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Crestone raised to date?

Crestone has raised obfuscated.

Overview

Crestone

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Crestone

CB Rank

44315

Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.

Founded

obfuscation

Private

Grant

Boulder, Colorado, United States

51-100

www.crestonepharma.com

Biopharma

Biotechnology

Health Care

Medical

Funding Rounds

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Nebojsa Janjic: Founder
Urs Ochsner: Co-founder,Vice President & CEO

Details

Legal Name

Crestone, Inc

Also Known As

Crestone Pharma

Operating Status

Active

Company Type

For Profit

Founders

John Rohloff, Nebojsa Janjic, Thale Jarvis, Urs Ochsner

About the Company

Crestone is a clinical-stage biopharmaceutical business that is developing novel medication candidates. The following are in the company's research pipeline: C. Treatments for C. diff, antibiotic-resistant Gram-positive infections, and tuberculosis.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CRS3123 for C. difficile

A small molecule drug candidate that inhibits bacterial protein synthesis to treat Clostridioides difficile infection (CDI).

CRS0540 Gram-positives

A novel small molecule antibiotic targeting the DNA polymerase PolC to treat resistant Gram-positive bacterial infections.

Research & Development

Crestone is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Crestone	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institute of Allergy and Infectious Diseases	Yes	Grant - Crestone	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Crestone	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Crestone	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Crestone	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Crestone	—